Literature DB >> 16647835

A possible dose-dependent teratogenic effect of ergotamine.

N Acs, F Bánhidy, E Puhó, A E Czeizel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16647835     DOI: 10.1016/j.reprotox.2006.03.002

Source DB:  PubMed          Journal:  Reprod Toxicol        ISSN: 0890-6238            Impact factor:   3.143


× No keyword cloud information.
  3 in total

1.  Delivery outcome after maternal use of drugs for migraine: a register study in Sweden.

Authors:  Bengt Källén; Emma Nilsson; Petra Otterblad Olausson
Journal:  Drug Saf       Date:  2011-08-01       Impact factor: 5.606

Review 2.  Ongoing Pharmacological Management of Chronic Pain in Pregnancy.

Authors:  Bengt Källén; Margareta Reis
Journal:  Drugs       Date:  2016-06       Impact factor: 9.546

3.  Ergotamine treatment during pregnancy and a higher rate of low birthweight and preterm birth.

Authors:  Ferenc Bánhidy; Nándor Acs; Erzsébet Puhó; Andrew E Czeizel
Journal:  Br J Clin Pharmacol       Date:  2007-05-15       Impact factor: 4.335

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.